Literature DB >> 12046079

Full-length core sequence dependent complex-type glycosylation of hepatitis C virus E2 glycoprotein.

Li-Xin Zhu1, Jing Liu, Ying-Chun Li, Yu-Ying Kong, Caroline Staib, Gerd Sutter, Yuan Wang, Guang-Di Li.   

Abstract

AIM: To study HCV polyprotein processing is important for the understanding of the natural history of HCV and the design of vaccines against HCV. The purpose of this study is to investigate the affection of context sequences on hepatitis C virus (HCV) E2 processing.
METHODS: HCV genes of different lengths were expressed and compared in vaccinia virus/T7 system with homologous patient serum S94 and mouse anti-serum M( E2116) raised against E.coli -derived E2 peptide, respectively. Deglycosylation analysis and GNA ( Galanthus nivalus ) lectin binding assay were performed to study the post-translational processing of the expressed products.
RESULTS: E2 glycoproteins with different molecular weights (-75 kDa and -60 kDa) were detected using S94 and M( E2116), respectively. Deglycosylation analysis showed that this difference was mainly due to different glycosylation. Endo H resistance and its failure to bind to GNA lectin demonstrated that the higher molecular weight form (75 kDa) of E2 was complex-type glycosylated, which was readily recognized by homologous patient serum S94. Expression of complex-type glycosylated E2 could not be detected in all of the core-truncated constructs tested, but readily detected in constructs encoding full-length core sequences.
CONCLUSION: The upstream conserved full-length core coding sequence was required for the production of E2 glycoproteins carrying complex-type N-glycans which reacted strongly with homologous patient serum and therefore possibly represented more mature forms of E2. As complex-type N-glycans indicated modification by Golgi enzymes, the results suggest that the presence of full-length core might be critical for E1/E2 complex to leave ER. Our data may contribute to a better understanding of the processing of HCV structural proteins as well as HCV morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12046079      PMCID: PMC4656430          DOI: 10.3748/wjg.v8.i3.499

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  52 in total

1.  The C-terminal region of the hepatitis C virus E1 glycoprotein confers localization within the endoplasmic reticulum.

Authors:  Mike Flint; Jane A McKeating
Journal:  J Gen Virol       Date:  1999-08       Impact factor: 3.891

2.  Hypervariable regions in the putative glycoprotein of hepatitis C virus.

Authors:  M Hijikata; N Kato; Y Ootsuyama; M Nakagawa; S Ohkoshi; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1991-02-28       Impact factor: 3.575

3.  Effect of Downstream Sequence on the Cleavage of Envelop Protein 1 Signal Sequence in Hepatitis C Virus.

Authors:  L X Zhu; Y Y Kong; Y Wang; G D Li
Journal:  Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)       Date:  2001

4.  Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro.

Authors:  Sylvie Rumin; Pascale Berthillon; Eiji Tanaka; Kendo Kiyosawa; Mary-Anne Trabaud; Thierry Bizollon; Christian Gouillat; Philippe Gripon; Christiane Guguen-Guillouzo; Geneviève Inchauspé; Christian Trépo
Journal:  J Gen Virol       Date:  1999-11       Impact factor: 3.891

Review 5.  Novel cell culture systems for the hepatitis C virus.

Authors:  R Bartenschlager; V Lohmann
Journal:  Antiviral Res       Date:  2001-10       Impact factor: 5.970

6.  Posttransfusion hepatitis C virus infection in children.

Authors:  Y H Ni; M H Chang; H C Lue; H Y Hsu; M J Wang; P J Chen; D S Chen
Journal:  J Pediatr       Date:  1994-05       Impact factor: 4.406

7.  Prevalence, genotypes, and an isolate (HC-C2) of hepatitis C virus in Chinese patients with liver disease.

Authors:  Y Wang; H Okamoto; F Tsuda; R Nagayama; Q M Tao; S Mishiro
Journal:  J Med Virol       Date:  1993-07       Impact factor: 2.327

8.  Expression and identification of hepatitis C virus polyprotein cleavage products.

Authors:  A Grakoui; C Wychowski; C Lin; S M Feinstone; C M Rice
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

9.  Mutations in hepatitis C virus RNAs conferring cell culture adaptation.

Authors:  V Lohmann; F Körner; A Dobierzewska; R Bartenschlager
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

10.  HCV cDNA transfection to HepG2 cells.

Authors:  N Hiramatsu; S Dash; M A Gerber
Journal:  J Viral Hepat       Date:  1997       Impact factor: 3.728

View more
  2 in total

1.  Purification and application of C-terminally truncated hepatitis C virus E1 proteins expressed in Escherichia coli.

Authors:  Jing Liu; Li-Xin Zhu; Yu-Ying Kong; Guang-Di Li; Yuan Wang
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

2.  Expression of hepatitis C virus envelope protein 2 induces apoptosis in cultured mammalian cells.

Authors:  Li-Xin Zhu; Jing Liu; You-Hua Xie; Yu-Ying Kong; Ye Ye; Chun-Lin Wang; Guang-Di Li; Yuan Wang
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.